Turns out there’s plenty of drama still to play out in the takeover battle for IVF business Virtus Health, including some seemingly underhanded allegations of misleading conduct.
If you were to believe a media push from the UK-based CapVest Partners camp on Thursday, you’d be excused for thinking Australian buyout firm BGH Capital had actively tried to mislead Virtus shareholders.
Loading...
Yolanda Redrup is the editor of the AFR Rich List. She previously reported on technology, healthcare and Street Talk. Connect with Yolanda on Twitter. Email Yolanda at yolanda.redrup@afr.com
Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@afr.com
Anthony Macdonald is a Chanticleer columnist. He is a former Street Talk co-editor and has 10 years' experience as a business journalist and worked at PwC, auditing and advising financial services companies. Connect with Anthony on Twitter. Email Anthony at a.macdonald@afr.com
